Aromatherapy Improved Management of Chemotherapy-Induced Nausea and Vomiting
Randomized trial compared effects of ginger oil, peppermint oil, and canola oil on CINV in patients receiving chemotherapy prior to bone marrow transplantation.
Randomized trial compared effects of ginger oil, peppermint oil, and canola oil on CINV in patients receiving chemotherapy prior to bone marrow transplantation.
Researchers conducted a literature search for evidence of the effects of medical marijuana products on symptom burden in patients with cancer.
A head-to-head comparison was conducted to determine the safety and efficacy of fosnetupitant with fosaprepitant in combination with palonosetron and dexamethasone.
A phase 3 clinical trial determined if adding aprepitant to antiemetic prophylaxis would further reduce the risks of chemotherapy-induced nausea and vomiting for women receiving chemotherapy for GI cancer.
Researchers explored the effectiveness of using an iPad-based, interactive game to educate first-time chemotherapy patients on prevention and self-management of CINV.
The level of control of acute-phase CIV in pediatric patients was lower in this study than has been reported for adult patients; control of delayed-phase CIV is also poor.
Engaging patients in a CRCMP for CINV allowed for rapid assessment of PROs by a pharmacist, reducing ED visits, hospitalizations, and urgent care use.
A prospective study demonstrated this treatment is an option for patients undergoing chemoradiation for gynecologic cancers who are at risk of late-onset CINV or noncompliance with oral therapy.
A randomized study determined the efficacy of adding peppermint essential oil to a cool wash cloth to ease nausea associated with chemotherapy.
Olanzapine added to triplet antiemetic therapy, has been shown to reduce risk of chemotherapy-induced nausea and vomiting, but can cause daytime sleepiness.